Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose hydrocortisone for ventilator-dependent preterm neonates with respiratory distress syndrome
IRCT20200721048155N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in respiratory distress syndrome (RDS) comparing Hydrocortisone plus dexamethasone with Control dexamethasone (2 arms). Primary endpoints: Status of need for mechanical ventilation and Duration of connection to the ventilation device. Started Feb 2020; status: completed.
02
Drugs
hydrocortisonedexamethasone
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20200721048155N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200721048155N1.